GlassScriptPhysician profile
Tony H Su
NPI 1366437865
$16,064.22
in general payments reported to CMS, 2019-2025
27 companies · $6,404 in 2025
The $6,404 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.82 · 2021: $11.64 · 2022: $2,265 · 2023: $5,465 · 2024: $1,821 · 2025: $6,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,917 · Education: $4,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,720 · Travel and Lodging: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,917.39 |
| Education | $4,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,720.00 |
| Travel and Lodging | $1,553.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,431.07 | 2023-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $2,279.30 | 2021-2025 | Illumisite |
| Glaxosmithkline, LLC. | $1,843.40 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Zoll Respicardia, INC. | $1,649.18 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $1,117.87 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Insmed, INC. | $511.71 | 2022-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $365.10 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.76 | 2022-2025 | Ofev |
| Mylan Specialty L.P. | $218.92 | 2022-2024 | Yupelri |
| Verona Pharma, INC. | $200.12 | 2025 | Ohtuvayre |
| Baxter Healthcare | $146.10 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $136.96 | 2023-2025 | Dupixent |
| Grifols USA, LLC | $115.55 | 2022-2024 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $103.66 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $96.82 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $92.38 | 2023-2025 | Tezspire |
| Genzyme Corporation | $87.44 | 2024 | |
| Philips North America LLC | $83.37 | 2024-2025 | Patient Interface Software, (Bo0) Hosp Vent Devices, (5091) Amd Und |
| Inogen, INC. | $57.46 | 2022-2025 | |
| Electromed, INC. | $54.59 | 2023-2025 | Smartvest |
| Viatris Specialty LLC | $25.54 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $23.31 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.79 | 2024 | Opsumit |
| Body Vision Medical INC. | $21.18 | 2024 | Lungvision |
| Merck Sharp & Dohme LLC | $20.01 | 2023 | |
| Shionogi INC | $17.99 | 2023 | Fetroja |
| Pinnacle Biologics, INC | $14.64 | 2025 | Photofrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.